Company / Current Assets per Share
FATE THERAPEUTICS INC Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.83
FY2025
5-year range
$1.83 / $7.22
FY2021-FY2025
Trend
-38.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 4 consecutive years, from $7.22 in FY2021 to $1.83 in FY2025.
Based on SEC 10-K filings.
1.83 in FY2025 with a 5-year CAGR of -22.4%.
Declined from $3.41 to $1.83 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -29.6%
- 5-Year CAGR
- -22.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- FATE THERAPEUTICS INC's current assets per share has declined for 4 consecutive years.
- In FY2025, current assets per share decreased 38.1% year-over-year.
- Peak current assets per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.83 | -38.1% |
| FY2024 | $2.96 | -13.1% |
| FY2023 | $3.41 | -35.0% |
| FY2022 | $5.24 | -27.4% |
| FY2021 | $7.22 | +10.6% |
| FY2020 | $6.53 | +86.0% |
| FY2019 | $3.51 | -9.9% |
| FY2018 | $3.90 | +57.2% |
| FY2017 | $2.48 | -23.7% |
| FY2016 | $3.25 | +1.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026